Design and synthesis of 4-Aminoquinoline-isoindoline-dione-isoniazid triads as potential anti-mycobacterials - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Bioorganic and Medicinal Chemistry Letters Année : 2020

Design and synthesis of 4-Aminoquinoline-isoindoline-dione-isoniazid triads as potential anti-mycobacterials

Résumé

A series of 4-aminoquinoline-isoindoline-dione-isoniazid triads were synthesized and assessed for their anti-mycobacterial activities and cytotoxicity. Most of the synthesized compounds exhibited promising activities against the mc26230 strain of M. tuberculosis with MIC in the range of 3.125-12.5 µg/mL and were non-cytotoxic against Vero cells. The conjugates lacking either isoniazid or quinoline core in their structural framework failed to inhibit the growth of M. tuberculosis; thus, further strengthening the proposed design of triads in the present study.
Fichier principal
Vignette du fichier
4-aminoquinoline-isoindoline-dione-INH-BMCL.pdf (2.87 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

inserm-03082751 , version 1 (18-12-2020)

Identifiants

Citer

Anu Rani, Matt Johansen, Françoise Roquet-Banères, Laurent Kremer, Paul Awolade, et al.. Design and synthesis of 4-Aminoquinoline-isoindoline-dione-isoniazid triads as potential anti-mycobacterials. Bioorganic and Medicinal Chemistry Letters, 2020, 30 (22), pp.127576. ⟨10.1016/j.bmcl.2020.127576⟩. ⟨inserm-03082751⟩
79 Consultations
136 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More